Global Pharmacovigilance And Drug Safety Software Market Size & Outlook

The global pharmacovigilance and drug safety software market size was estimated at USD 211.0 million in 2024 and is projected to reach USD 388.7 million by 2033, growing at a CAGR of 7.1% from 2025 to 2033.
Revenue, 2024 (US$M)
$211.0
Forecast, 2033 (US$M)
$388.7
CAGR, 2025 - 2033
7.1%
Report Coverage
Worldwide

Global pharmacovigilance and drug safety software market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Global pharmacovigilance and drug safety software market highlights

  • The global pharmacovigilance and drug safety software market generated a revenue of USD 211.0 million in 2024 and is expected to reach USD 388.7 million by 2033.
  • The market is expected to grow at a CAGR (2025 - 2033) of 7.1% by 2033.
  • In terms of segment, on-demand accounted for a revenue of USD 130.0 million in 2024.
  • On-Demand is the most lucrative delivery mode segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2033.

Global data book summary

Market revenue in 2024USD 211.0 million
Market revenue in 2033USD 388.7 million
Growth rate7.1% (CAGR from 2025 to 2033)
Largest segmentOn-demand
Fastest growing segmentOn-Demand
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationOn-Demand, On-Premise

Other key industry trends

  • In terms of revenue, the North America accounted for 32.1% of the global pharmacovigilance and drug safety software market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, India is the fastest growing regional market and is projected to reach USD 11.8 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmacovigilance And Drug Safety Software Market Companies

Name Profile # Employees HQ Website
Capgemini SE View profile 340400 11 rue de Tilsitt, Paris, France, 75017 https://www.capgemini.com
ArisGlobal View profile 1001-5000 Coral Gables, Florida, United States, North America https://www.arisglobal.com
PAREXEL View profile 10001+ Waltham, Massachusetts, United States, North America http://www.parexel.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Cognizant Technology Solutions Corp Class A View profile 344400 300 Frank West Burr Boulevard, Suite 36, 6th Floor, Teaneck, NJ, United States, 07666 https://www.cognizant.com
Accenture PLC Class A View profile 742000 1 Grand Canal Square, Grand Canal Harbour, Dublin, Ireland, 2 https://www.accenture.com
International Business Machines Corp View profile 282200 One New Orchard Road, Armonk, NY, United States, 10504 http://www.ibm.com
Oracle Corp View profile 164000 2300 Oracle Way, Austin, TX, United States, 78741 https://www.oracle.com

Global pharmacovigilance and drug safety software market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmacovigilance and drug safety software market will help companies and investors design strategic landscapes.


On-demand was the largest segment with a revenue share of 61.61% in 2024. Horizon Databook has segmented the Global pharmacovigilance and drug safety software market based on on-demand, on-premise covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Pharmacovigilance And Drug Safety Software Delivery Mode Outlook (Revenue, USD Million, 2021-2033)
    • On-Premise
    • On-Demand
  • Global Pharmacovigilance And Drug Safety Software End Use Outlook (Revenue, USD Million, 2021-2033)
    • Others
    • Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
    • CROs/BPOs or PV service providers when outsourced
  • Global Pharmacovigilance And Drug Safety Software Functionality Outlook (Revenue, USD Million, 2021-2033)
    • Adverse event reporting and analysis
    • Signal detection and other safety risk assessment
    • Case data collection and management

Reasons to subscribe to Global pharmacovigilance and drug safety software market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global pharmacovigilance and drug safety software market databook

  • Our clientele includes a mix of pharmacovigilance and drug safety software market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global pharmacovigilance and drug safety software market , including forecasts for subscribers. This global databook contains high-level insights into Global pharmacovigilance and drug safety software market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global pharmacovigilance and drug safety software market size, by regions, 2021-2033 (US$M)

Top 10 countries: Pharmacovigilance and drug safety software market size, 2024 (US$M)

Global pharmacovigilance and drug safety software market share, by delivery mode, 2024 & 2033 (%, US$M)

Pharmacovigilance and drug safety software market: Opportunity assessment by country

Global pharmacovigilance and drug safety software market, by region, 2024 (US$M)

Global pharmacovigilance and drug safety software market size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online